Takeshi Sugaya Selected Research

Fatty Acid-Binding Proteins

1/2022	Accuracy of Liver-Type Fatty Acid-Binding Protein in Predicting Acute Kidney Injury: A Meta-Analysis.
4/2021	Preliminary study of urinary excretion of liver-type fatty acid-binding protein in a cat model of chronic kidney disease.
1/2021	Urinary liver-type fatty acid-binding protein is independently associated with graft failure in outpatient kidney transplant recipients.
3/2020	Renal expression and urinary excretion of liver-type fatty acid-binding protein in cats with renal disease.
1/2020	Relationship between Urinary Liver-Type Fatty Acid-Binding Protein (L-FABP) and Sarcopenia in Spontaneously Diabetic Torii Fatty Rats.
12/2019	Temporal changes in urinary excretion of liver-type fatty acid binding protein (L-FABP) in acute kidney injury model of domestic cats: a preliminary study.
6/2019	Serum Liver-Type Fatty Acid-Binding Protein Is a Possible Prognostic Factor in Human Chronic Liver Diseases From Chronic Hepatitis to Liver Cirrhosis and Hepatocellular Carcinoma.
1/2019	The Possibility of Urinary Liver-Type Fatty Acid-Binding Protein as a Biomarker of Renal Hypoxia in Spontaneously Diabetic Torii Fatty Rats.
1/2018	Urinary liver-type fatty acid-binding protein is associated with subendocardial viability ratio in middle- and older-aged adults.
1/2018	Urinary Level of Liver-Type Fatty Acid Binding Protein Reflects the Degree of Tubulointerstitial Damage in Polycystic Kidney Disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takeshi Sugaya Research Topics

Disease

21	Chronic Renal Insufficiency 04/2021 - 11/2002
21	Fibrosis (Cirrhosis) 01/2020 - 02/2001
17	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 10/2006
16	Diabetic Nephropathies (Diabetic Nephropathy) 04/2021 - 11/2005
12	Inflammation (Inflammations) 01/2021 - 05/2004
11	Proteinuria 02/2016 - 11/2002
10	Hypertension (High Blood Pressure) 01/2022 - 02/2004
10	Hypoxia (Hypoxemia) 01/2021 - 11/2007
10	Kidney Diseases (Kidney Disease) 02/2014 - 12/2003
9	Ischemia 01/2021 - 03/2002
8	Neoplasms (Cancer) 07/2022 - 07/2003
8	Chronic Kidney Failure (Chronic Renal Failure) 04/2016 - 11/2005
7	Type 2 Diabetes Mellitus (MODY) 01/2022 - 09/2006
7	Ulcerative Colitis 11/2021 - 07/2016
5	Reperfusion Injury 11/2019 - 09/2006
5	Necrosis 11/2019 - 12/2003
5	Hemorrhage 01/2018 - 10/2006
5	Glomerulonephritis 01/2012 - 09/2005
4	Body Weight (Weight, Body) 04/2021 - 12/2003
4	Crohn Disease (Crohn's Disease) 01/2021 - 01/2017
4	Cardiovascular Diseases (Cardiovascular Disease) 05/2018 - 05/2013
4	Ureteral Obstruction 06/2012 - 06/2004
3	Sclerosis 04/2021 - 01/2017
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 10/2018
3	Liver Diseases (Liver Disease) 06/2019 - 01/2008
3	Hepatocellular Carcinoma (Hepatoma) 06/2019 - 04/2010
3	Liver Cirrhosis (Hepatic Cirrhosis) 06/2019 - 07/2008
3	Sepsis (Septicemia) 03/2016 - 05/2009
3	Myocardial Infarction 01/2016 - 04/2004
3	IGA Glomerulonephritis (IGA Nephropathy) 07/2011 - 09/2005
3	Septic Shock (Toxic Shock Syndrome) 12/2010 - 05/2009
3	Disease Progression 12/2007 - 03/2005
2	Starvation 07/2022 - 06/2021
2	Hyperlipidemias (Hyperlipidemia) 01/2022 - 04/2021
2	Obesity 04/2021 - 01/2016
2	Hyperglycemia 04/2021 - 02/2014
2	Chronic Hepatitis (Chronic Active Hepatitis) 06/2019 - 03/2005
2	Myocardial Ischemia (Ischemic Heart Diseases) 05/2015 - 06/2012
2	Cardiomyopathies (Cardiomyopathy) 06/2012 - 07/2002
2	Wounds and Injuries (Trauma) 06/2012 - 04/2009
2	Albuminuria 03/2011 - 09/2009
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 06/2010 - 09/2009
2	Pancreatitis 02/2010 - 07/2004
2	Atherosclerosis 02/2010 - 07/2008

Drug/Important Bio-Agent (IBA)

58	Fatty Acid-Binding ProteinsIBA 01/2022 - 03/2003
29	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2003
16	Angiotensin IIIBA 01/2017 - 02/2001
14	Type 1 Angiotensin ReceptorIBA 01/2021 - 02/2001
14	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2002
14	CreatinineIBA 02/2016 - 03/2005
13	AlbuminsIBA 04/2021 - 01/2004
7	Nonesterified Fatty Acids (NEFA)IBA 02/2016 - 11/2002
6	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 11/2011 - 05/2003
5	Cisplatin (Platino)FDA LinkGeneric 06/2021 - 01/2008
5	Pharmaceutical PreparationsIBA 01/2021 - 04/2010
5	Urea (Carbamide)FDA LinkGeneric 03/2016 - 10/2006
5	Messenger RNA (mRNA)IBA 12/2013 - 11/2006
4	Blood Glucose (Blood Sugar)IBA 01/2022 - 02/2016
4	AntioxidantsIBA 12/2019 - 01/2011
4	SaltsIBA 01/2018 - 10/2013
4	Angiotensin Receptor AntagonistsIBA 09/2010 - 10/2005
4	NitrogenIBA 01/2010 - 10/2006
4	ReninIBA 07/2006 - 10/2002
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 01/2009
3	SteroidsIBA 10/2021 - 02/2010
3	EnzymesIBA 01/2021 - 09/2005
3	Adenine FDA LinkGeneric 11/2017 - 12/2013
3	Contrast MediaIBA 05/2015 - 03/2006
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 06/2012 - 12/2003
3	CytokinesIBA 11/2011 - 01/2011
3	Telmisartan (Micardis)FDA Link 09/2010 - 10/2008
3	candesartan cilexetil (Amias)FDA Link 10/2005 - 03/2002
2	Xanthine DehydrogenaseIBA 01/2022 - 05/2018
2	Liraglutide FDA Link 01/2022 - 04/2021
2	Glucagon-Like Peptide-1 ReceptorIBA 01/2022 - 04/2021
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 06/2011
2	C-Reactive ProteinIBA 01/2021 - 01/2017
2	salicylhydroxamic acid (SHAM)IBA 12/2019 - 10/2010
2	AldosteroneIBA 10/2019 - 01/2018
2	Adalimumab (Humira)FDA Link 10/2019 - 05/2018
2	acarboxyprothrombin (PIVKA)IBA 06/2019 - 04/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 12/2016
2	PalmitatesIBA 12/2016 - 09/2011
2	Hexosaminidases (Hexosaminidase)IBA 04/2016 - 11/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2013 - 12/2003
2	CollagenIBA 06/2012 - 10/2008
2	Immunoglobulin G (IgG)IBA 06/2012 - 01/2008
2	AntibodiesIBA 06/2012 - 04/2010
2	Transforming Growth Factor beta (TGF-beta)IBA 11/2011 - 03/2007
2	Lipocalin-2IBA 11/2011 - 12/2010
2	aristolochic acid I (aristolochic acid)IBA 03/2011 - 12/2003
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2010 - 09/2004
2	ImmunosorbentsIBA 06/2010 - 09/2005
2	Amlodipine (Norvasc)FDA LinkGeneric 02/2010 - 06/2007

Therapy/Procedure

12	Therapeutics 07/2022 - 11/2007
3	Renal Dialysis (Hemodialysis) 05/2013 - 11/2005
2	Oral Administration 10/2021 - 02/2016
2	Remission Induction 11/2020 - 04/2019
2	Critical Care (Surgical Intensive Care) 11/2011 - 05/2009